Role of the microcin B17 propeptide in substrate recognition: Solution structure and mutational analysis of McbA1-26

Chemistry and Biology

Volumn 5, Issue 4, 1998, Pages 217-228

  Roy, Ranabir Sinha ^a   Kim, Soyoun ^b   Baleja, James D ^b   Walsh, Christopher T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Leader; Microcin B17; Mutagenesis; Nuclear magnetic resonance; Propeptide

Indexed keywords

EID: 0032054255     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(98)90635-4     Document Type: Article

References (54)

1. Kolter, R. & Moreno, F. (1992). Genetics of ribosomally synthesized peptide antibiotics. Annu. Rev. Microbiol., 141-163.
2. Jack, R.W., Tagg, J.R. & Ray, B. (1997). Bacteriocins of gram-positive bacteria. Microbiol. Rev. 59, 171-200.
3. Moreno, F., San Millán, J.L., Hernández-Chico, C. & Kolter, R. (1995). Microcins. In Genetics and Biochemistry of Antibiotic Production. (Vining, C.L. & Stuttard, C., eds), pp. 307-321, Butterworth-Heinemann, Boston.
4. Davagnino, J., Herrero, M., Furlong, D., Moreno, F. & Kolter, R. (1986). The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine. Proteins: Struct. Funct. Genet 1, 230-238.
5. Bayer, A., Freund, S., Nicholson, G. & Jung, G. (1993). Posttranslational backbone modifications in the ribosomal biosynthesis of the glycine-rich antibiotic microcin B17. Angew. Chem. Int. Ed. Engl. 32, 1336-1339.
6. Yorgey, P., Davagnino, J. & Kolter, R. (1993). The maturation pathway of microcin B17, a peptide inhibitor of DNA gyrase. Mol. Microbiol. 9, 897-905.
7. Yorgey, P., et al., & Kolter, R. (1994). Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor. Proc. Natl Acad. Sci. USA 91, 4519-4523.
8. Li, Y.-M., Milne, J.C., Madison, L.L., Kolter, R. & Walsh, C.T. (1996). From peptide precursors to oxazole and thiazole-containing peptide antibiotics: Microcin B17 synthase. Science 274, 1188-1193.
9. Garrido, M.C., Herrero, M., Kolter, R. & Moreno, F. (1988). The export of the DNA replication inhibitor microcin B17 provides immunity for the host cell. EMBO J. 7, 1853-1862.
10. Fath, M.J. & Kolter, R. (1993). ABC transporters: Bacterial exporters. Microbiol. Rev. 57, 995-1017.
11. San Millán, J.L., Kolter, R. & Moreno, F. (1985). Cloning and mapping of the genetic determinants for microcin-B17. J. Bacteriol. 163, 275-281.
12. San Millán, J.L., Kolter, R. & Moreno, F. (1985). Plasmid genes required for microcin B-17 production. J. Bacteriol. 163, 1016-1020.
13. den Blaauwen, T. & Driessen, A.J.M. (1996). Sec-dependent preprotein translocation in bacteria. Arch. Microbiol. 165, 1-8.
14. Madison, L.L., Vivas, I.E., Li, Y.-M., Walsh, C.T. & Kolter, R. (1997). The leader peptide is essential for the post-translational modification of the DNA gyrase inhibitor microcin B17. Mol. Microbiol. 23, 161-168.
15. Hubbard, B.R., Jacobs, M., Ulrich, M.M.W., Walsh, C., Furie, B, & Furie, B.C. (1989). Vitamin-K-dependent carboxylation - in vitro modification of synthetic peptides containing the γ-carboxylation recognition site. J. Biol. Chem. 264, 14145-14150.
16. Huber, P., et al., & Furie, B. (1990). Identification of amino acids in the γ-carboxylation recognition site on the propeptide of prothrombin. J. Biol. Chem. 265, 12467-12473.
17. Furie, B. & Furie, B.C. (1988). The molecular basis of blood-coagulation. Cell 53, 505-518.
18. de Vos, W.M., Kuipers, O.P., van der Meer, J.R. & Siezen, R.J. (1995). Maturation pathway of nisin and other lantibiotics: Post translationally modified antimicrobial peptides exported by gram-positive bacteria. Mol. Microbiol. 17, 427-437.
19. van Belkum, M.J., Worobo, R.W. & Stiles, M.E. (1997). Double-glycine-type leader peptides direct secretion of bacteriocins by ABC transporters: Colicin V secretion in lactococcus lactis. Mol. Microbiol. 23, 1293-1301.
20. Chou, P.Y. & Fasman, G.D. (1978). Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 47, 45-148.
21. Woody, R.W. (1996). Theory of circular dichroism of proteins. In Circular Dichroism and the Conformational Analysis of Biomolecules. (Fasman, G.D., ed.), pp. 25-67, Plenum Press, New York.
22. Szyperski, T., Güntert, P., Otting, G. & Wüthrich, K. (1992). Determination of scalar coupling constant by inverse fourier transform of in-phase multiplets. J. Magn. Res. 99, 552-560.
23. 1H chemical shifts obtained as a function of temperature and trifluoroethanol concentration for the peptide series GGXGG. J. Biomol. NMR 5, 14-24.
24. Wishart, D.S., Sykes, B.D. & Richards, F.M. (1991). Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J. Mol. Biol. 222, 311-333.
25. Hyberts, S.G., Goldberg, M.S., Havel, T.F. & Wagner, G. (1992). The solution structure of eglin C based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. Protein Sci. 1, 736-751.
26. 1H NMR. Biochemistry 30, 9040-9046.
27. Wüthrich, K. (1986). NMR of Proteins and Nucleic Acids. Wiley, New York.
28. Laskowski, R.A., Macarthur, M.W., Moss, D.S. & Thornton, J.M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291.
29. Ulrich, M.M.W., Furie, B., Jacobs, M.R., Vermeer, C. & Furie, B.C. (1988). Vitamin K-dependent carboxylation: a synthetic peptide based upon the γ-carboxylation recognition site sequence of the prothrombin propeptide is an active substrate for the carboxylase in vitro. J. Biol. Chem. 263, 9697-9702.
30. Sinha Roy, R., Belshaw, P.J. & Walsh, C.T. (1998). Mutational analysis of posttranslational heterocycle biosynthesis in the gyrase inhibitor microcin B17: Distance dependence from propeptide and tolerance for substitution in a GSCG cyclizable sequence. Biochemistry 37, 4125-4136.
31. + salt bridges in short peptides of de novo design. Proc. Natl Acad. Sci. USA 84, 8898-8902.
32. Lyu, P.C., Marky, L.A. & Kallenbach, N.R. (1989). The role of ion-pairs in α-helix stability - 2 new designed helical peptides. J. Am. Chem. Soc. 111, 2733-2734.
33. Scholtz, J.M., Qian, H., Robbins, V.H. & Baldwin, R.L. (1993). The energetics of ion-pair and hydrogen-bonding interactions in a helical peptide. Biochemistry 32, 9668-9676.
34. Yorgey, P.S. (1993). The structure and biosynthesis of microcin B17, a novel DNA gyrase inhibitor. Ph.D. Thesis, Harvard University, Cambridge.
35. Jung, G. (1991). Lantibiotics - ribosomally synthesized biologically active polypeptides containing sulfide bridges and α,β-didehydroamino acids. Angew. Chem. Int. Ed. Engl. 30, 1051-1192.
36. Vizán, J.L., Hernández-Chico, C., del Castillo, I. & Moreno, F. (1991). The peptide antibiotic microcin B17 induces double-stranded cleavage of DNA mediated by E. coli. DNA gyrase. EMBO J. 10, 467-476.
37. Cheng, J.-W., Chen, C., Huang, T.-H., Chou, S.-H. & Chen, S.-H. (1995). Conformation of the propeptide domain of factor IX. Biochim. Biophys. Acts 1245, 227-331.
38. van den Hooven, H.W., Rollema, H.S., Siezen, R.J., Hilbers, C.W. & Kuipers, O.P. (1997). Structural features of the final intermediate in the biosynthesis of the lantibiotic nisin. Influence of the leader peptide. Biochemistry 36, 14137-14145.
39. Sanford, D.G., Kanagy, C., Sudmeier, J.L., Furie, B.C., Furie, B. & Bachovchin, W.W. (1991). Structure of the propeptide of prothrombin containing the γ-carboxylation recognition site determined by two-dimensional NMR spectroscopy. Biochemistry 30, 9835-9841.
40. Sönnichsen, F.D., Van Eyk, J.E., Hodges, R.S. & Sykes, B.D. (1992). Effect of trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin peptide. Biochemistry 31, 8790-8798.
41. Najbar, L.V., Craik, D.J., Wade, J.D., Salvatore, D. & McLeish, M.J. (1997). Conformational analysis of LYS(11-36), a peptide derived from the β-Sheet region of T4 lysozyme, in TFE and SDS. Biochemistry 36, 11525-11533.
42. Breil, B.T., Ludden, P.W. & Triplett, E.W. (1993). DNA sequence and mutational analysis of genes involved in the production and resistance of the antibiotic peptide trifolitoxin. J. Bacteriol. 175, 3693-3702.
43. Lethbridge, B.J. (1989). The structure of trifolitoxin. Ph.D. Thesis, University of Adelaide, Adelaide.
44. Dunne, S.J., Cornell, R.B., Johnson, J.E., Glover, N.R. & Tracey, A.S. (1996). Structure of the membrane binding domain of CTP: phosphocholine cytidyltransferase. Biochemistry 35, 11975-11984.
45. Blumenthal, D.K., et al., & Krebs, E.G. (1985). Identification of the calmodulin-binding domain of skeletal-muscle myosin light chain kinase. Proc. Natl Acad. Sci. USA 82, 3187-3191.
46. Takio, K., Blumenthal, D.K., Walsh, K.A., Titani, K. & Krebs, E.G. (1986). Amino-acid sequence of rabbit-muscle myosin light chain kinase. Biochemistry 25, 8049-8057.
47. McCafferty, D.G., Lessard, I.A.D. & Walsh, C.T. (1997). Mutational analysis of potential zinc-binding residues in the active site of the enterococcal D-Ala-D-Ala dipeptidase VanX. Biochemistry 36, 10498-10505.
48. Fields, G.B. & Noble, R.L. (1990). Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pep. Protein Res. 35, 161-214.
49. Cavanagh, J., Fairbrother, W.J., Palmer III, A.G. & Skelton, N.J. (1996). Protein NMR Spectroscopy, Academic Press, San Diego.
50. Ludvigsen, S. & Poulsen, P.M. (1992). Positive theta-angles in proteins by nuclear magnetic resonance spectroscopy. J. Biomol. NMR 2, 227-233.
51. Freedman, S.J., Sanford, D.G., Bachovchin, W.W., Furie, B.C., Baleja, J.D. & Furie, B. (1996). Structure and function of the epidermal growth factor domain of P-selectin. Biochemistry 35, 13733-13744.
52. Freedman, S.J., Furie, B.C., Furie, C. & Baleja, J.D. (1995). Structure of the calcium ion-bound γ-carboxyglutamic acid-rich domain of factor IX. Biochemistry 34, 12126-12137.
53. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, (2nd edn), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
54. Deng, W.P. & Nickoloff, JA (1992). Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200, 81-88.